Summit Pharmaceuticals International Corp:企業の戦略的SWOT分析

◆英語タイトル:Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review
◆商品コード:DATA904C2519
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summit Pharmaceuticals International Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Summit Pharmaceuticals International Corp (Summit Pharmaceuticals), a subsidiary of Sumitomo Corp, is a pharmaceutical company that commercializes pharmaceuticals, quasi-drugs and medical devices. It provides drug discovery services, drug discovery instruments and bioresource materials, pharmaceutical development and supply of APIs, intermediates and formulations. The company offers services in research and development assistance to pharmaceutical companies ranging from the assistance with original drug research to the arranging of licensing, production. Summit Pharmaceuticals also imports and exports new drugs and diagnostic products. The company also provides optimal formulations and ingredients to various cosmetics manufacturers. It distributes support tools for drug discovery such as, plants, microorganisms, cells and tissues from animals and chemical library. It also provides consulting services. Summit Pharmaceuticals is headquartered in Chuo-Ku, Tokyo, Japan.

Summit Pharmaceuticals International Corp Key Recent Developments

Jun 15,2018: Japanese Patent Office Grants Broad Claims Covering CRISPR/Cas9 Gene Editing Technology
Jun 14,2017: Hitachi: Successful Identification of Metabolite Differences in Urine between Healthy, Breast Cancer and Colorectal Cancer Groups

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
Summit Pharmaceuticals International Corp – Key Facts 5
Summit Pharmaceuticals International Corp – Key Employees 6
Summit Pharmaceuticals International Corp – Major Products and Services 7
Summit Pharmaceuticals International Corp – History 8
Summit Pharmaceuticals International Corp – Locations And Subsidiaries 9
Head Office 9
Other Locations & Subsidiaries 9
Section 2 – Company Analysis 10
Company Overview 10
Summit Pharmaceuticals International Corp – Business Description 11
Summit Pharmaceuticals International Corp – SWOT Analysis 12
SWOT Analysis – Overview 12
Summit Pharmaceuticals International Corp – Strengths 12
Summit Pharmaceuticals International Corp – Weaknesses 13
Summit Pharmaceuticals International Corp – Opportunities 14
Summit Pharmaceuticals International Corp – Threats 15
Summit Pharmaceuticals International Corp – Key Competitors 16
Summit Pharmaceuticals International Corp, Recent Deals Summary 17
Section 3 – Company’s Recent Developments 18
Jun 15, 2018: Japanese Patent Office Grants Broad Claims Covering CRISPR/Cas9 Gene Editing Technology 18
Jun 14, 2017: Hitachi: Successful Identification of Metabolite Differences in Urine between Healthy, Breast Cancer and Colorectal Cancer Groups 19
Section 4 – Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Summit Pharmaceuticals International Corp, Key Facts 5
Summit Pharmaceuticals International Corp, Key Employees 6
Summit Pharmaceuticals International Corp, Major Products and Services 7
Summit Pharmaceuticals International Corp, History 8
Summit Pharmaceuticals International Corp, Other Locations 9
Summit Pharmaceuticals International Corp, Key Competitors 16
Summit Pharmaceuticals International Corp, Recent Deals Summary 17

★海外企業調査レポート[Summit Pharmaceuticals International Corp:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catholic University of Leuven:製薬・医療:M&Aディール及び事業提携情報
    Summary Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, …
  • Quest PharmaTech Inc (QPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Quest PharmaTech Inc (Quest), formerly Altachem Pharma Ltd is a pharmaceutical company that develops antibody based immunotherapeutic products for the treatment of cancer. The company develops products for treatment of cancer by combining immunotherapeutic antibodies with immunoglobulin G or …
  • Boehringer Ingelheim GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biophar …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • SurgaColl Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops novel tissue regeneration products for the surgical treatment of disease of the bone, cartilage and other human tissue. The company’s products include hydroxycoll and chondrocoll. Its hydroxycoll is …
  • Marsh & McLennan Companies Inc:企業の戦略・SWOT・財務分析
    Marsh & McLennan Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Marsh & McLennan Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sime Darby Bhd (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Bhd (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Firalis SAS:企業の製品パイプライン分析2018
    Summary Firalis SAS (Firalis) is a biotechnology company that develops biomarkers and biomarker-based diagnostic kits. The company’s biomarker products comprise recombinant proteins and calibrants, Elisa kits, and monoclonal antibodies, among others. It offers biomarker services such as flow cytomet …
  • EnGeneIC Ltd-製薬・医療分野:企業M&A・提携分析
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • Bertelsmann SE & Co KgaA:企業の戦略的SWOT分析
    Bertelsmann SE & Co KgaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Unichem Laboratories Ltd (UNICHEMLAB):企業の財務・戦略的SWOT分析
    Summary Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API's). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, …
  • Fountain Biopharma Inc (4159):製薬・医療:M&Aディール及び事業提携情報
    Summary Fountain Biopharma Inc (Fountain Biopharma), a subsidiary of Microbio Co Ltd, is a developer of therapeutic monoclonal antibodies and DNA aptamers. The company’s technologies include IgE development platform, IEA’s drug development platform and tumor stem cell culture platform. Its IgE devel …
  • EnergyAustralia Pty Ltd:企業の戦略的SWOT分析
    EnergyAustralia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • Cytori Therapeutics Inc (CYTX)-医療機器分野:企業M&A・提携分析
    Summary Cytori Therapeutics Inc (Cytori) is a clinical stage regenerative medicine company. It develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two …
  • FireEye, Inc.:企業のM&A・事業提携・投資動向
    FireEye, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FireEye, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Norgine BV:企業の戦略的SWOT分析
    Norgine BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Premaitha Health Plc (NIPT)-医療機器分野:企業M&A・提携分析
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Nestle SA:企業の戦略・SWOT・財務情報
    Nestle SA - Strategy, SWOT and Corporate Finance Report Summary Nestle SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆